Majority of the breast cancer patients were classified as ER, PR positive (n = 76, 71.03%; n = 68, 63.55%, respectively) in comparison to the patients with negative ER, PR status (n = 27, 25.23%; n = 35, 32.71, respectively). This evidence concerns the gene PGR and breast carcinoma.